Henry Schein | HSIC - Cash And Equivalent


Henry Schein reported $138M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Agilent USD 1.81B 49M Mar/2026
Align Technology USD 1.06B 35.07M Mar/2026
Bruker USD 133.4M 165.4M Mar/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Cigna USD 7.04B 636M Mar/2026
Concord Medical Services Hldg CNY 243.38M 85.1M Jun/2023
Cooper Companies USD 124.9M 14.3M Dec/2025
CVS Health USD 9.54B 1.09B Mar/2026
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 190M 136M Mar/2026
Encompass Health USD 110.5M 38.3M Mar/2026
Henry Schein USD 138M 18M Mar/2026
Idexx Laboratories USD 200.53M 20.46M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Laboratory Of America USD 981.1M 448.8M Mar/2026
McKesson USD 3.98B 1.02B Mar/2026
Mettler Toledo International USD 66.89M 2.18M Dec/2025
Owens Minor USD 336.88M 54.89M Mar/2026
Quest Diagnostics USD 393M 27M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Stryker USD 2.88B 1.13B Mar/2026
Tenet Healthcare USD 2.97B 84M Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Universal Health Services USD 119.03M 18.77M Mar/2026
Veradigm USD 492.6M 7.57M Sep/2022
Waters USD 462M 125.83M Mar/2026
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026
Zoetis USD 1.94B 369M Mar/2026